Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001301120-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 9, 2026 |
| Document Date | Jan 8, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
39,000
Total Value
$35,733.10
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jan 8, 2026 | Exercise/Conversion | 13,000 | $0.06 | $780.00 | 13,000 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 8, 2026 | Sale | 13,000 | $2.69 | $34,953.10 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jan 8, 2026 | Exercise/Conversion | 13,000 | $0.00 | $0.00 | 339,186 | Direct | โ | View Details |